Ex-global head of Pfizer R&D John LaMattina has been given a strategic advisory role by biotech firm Ziarco.
LaMattina spent 30 years at Pfizer having joined as a medicinal chemist in 1977.
John LaMattina takes on advisory role at Ziarco
Ex-global head of Pfizer R&D John LaMattina has been given a strategic advisory role by biotech firm Ziarco. LaMattina spent 30 years at Pfizer having joined as a medicinal chemist in 1977.
Tags
Related posts
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
- CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines
- Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
- New UK report highlights inequalities among people living with breast cancer
- ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
